Metropolis Healthcare Ltd - 542650 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended December 31, 2022 received from Link Intime India Private Limited, Registrar & Share Transfer Agent of the Company. Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Nomination and Remuneration Committee of the Board of the Directors of the Company vide circular resolution dated January 07, 2023 have approved the allotment of 4,372 (Four Thousand Three Hundred and Seventy-Two) Equity shares of Rs.2/- (Rupees Two Only) each at an exercise price of Rs. 2/- (Rupees Two Only) each aggregating to Rs. 8,744 (Rupees Eight Thousand Seven Hundred and Forty-Four Only) against the Restrictive Stock Units ('RSU') vested in and exercised by the employees of the Company under the MHL- Restrictive Stock Unit Plan, 2020. Metropolis Healthcare Ltd - 542650 - Closure of Trading Window
Metropolis Healthcare Limited has informed the Exchange that the trading window for dealing in securities of the Company by the Designated Persons of the Company and/or their immediate relatives will be closed with effect from Sunday, January 01, 2023 and shall remain closed up to 48 (Forty-Eight) hours after the declaration of the Financial Results of the Company for the quarter ended December 31, 2022. The date of the Board Meeting for approval of Financial Results of the Company for the quarter ended December 31, 2022 shall be intimated in due course.
Metropolis Healthcare appoints Surendran Chemmenkotil as CEO
Surendran Chemmenkotil will be joining Metropolis from Airtel Networks Ltd, Nigeria, where he worked as Managing Director and Chief Executive Officer (CEO). Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is the Press Release as mentioned below: Mr. Surendran Chemmenkotil to join as the Chief Executive Officer (CEO) of Metropolis Healthcare Limited. You are requested to take the above information on record. Metropolis Healthcare Ltd - 542650 - Board Meeting Outcome for Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
This is to inform you that based on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of the Company in their Meeting held today i.e. Friday, December 09, 2022, have inter-alia: Approved the appointment of Mr. Surendran Chemmenkotil as Chief Executive Officer ('CEO') of the Company w.e.f. January 02, 2023; 2. Accepted and took on record the resignation of Ms. Simmi Singh Bisht from the post of Company Secretary and Compliance Officer of the Company (Designated as Head - Legal and Secretarial) w.e.f. January 07, 2023; 3. Approved the appointment of Ms. Neha Shah, Associate Company Secretary (Membership No. ACS 51465) as an Interim Compliance Officer of the Company w.e.f. January 08, 2023. Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GIM India Equity Active Open Mother Fund & Others Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JP Morgan Asset Management (Asia Pacific) Ltd & Others Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GIM India Equity Active Open Mother Fund & Others Metropolis Healthcare Ltd - 542650 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for JP Morgan Asset Management (Asia Pacific) Ltd & Others